Web-Derek_Mazur-8517-Edit- (Zoom)

Derek Mazur Senior Associate

Derek joined Santé Ventures in 2014. Prior to joining the firm, Derek was with Houlihan Lokey in their Healthcare Mergers & Acquisitions practice based in Chicago. Before Houlihan, Derek was in the Investment Banking Division at SunTrust Robinson Humphrey based in Atlanta, where he focused on a variety of syndicated & leveraged finance, capital markets, and financial advisory engagements. Derek currently serves as a Board Observer at Iterion Therapeutics, a clinical stage oncology company, and Remedy, an on demand urgent care service that brings the doctor to you. Derek has a Masters of Science in Biotechnology from Johns Hopkins University, as well as a Bachelors of Business Administration in Finance from Emory University.

News
July 10, 2019 Geneos Therapeutics Announces First Patient Dosed with its DNA-based, Neoantigen-Targeting Personalized Vaccine Technology
Read More
June 26, 2019 Remedy Raises $10 Million to Bring Quality Care Closer to Patients
Read More